These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 33409683)
1. Effects of angiotensin II receptor blockers on serum levels of epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids in patients admitted to a cardiovascular center. Kato Y; Senda A; Mukai Y; Yamashita M; Sasaoka Y; Hanada M; Hongo F; Hirokami M; Rane A; Inotsume N; Toda T Eur J Clin Pharmacol; 2021 Jun; 77(6):887-894. PubMed ID: 33409683 [TBL] [Abstract][Full Text] [Related]
2. Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid via CYP2C8. Senda A; Mukai Y; Toda T; Hayakawa T; Yamashita M; Eliasson E; Rane A; Inotsume N Biol Pharm Bull; 2015; 38(12):1975-9. PubMed ID: 26632190 [TBL] [Abstract][Full Text] [Related]
3. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition. Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous Determination Method of Epoxyeicosatrienoic Acids and Dihydroxyeicosatrienoic Acids by LC-MS/MS System. Mukai Y; Toda T; Takeuchi S; Senda A; Yamashita M; Eliasson E; Rane A; Inotsume N Biol Pharm Bull; 2015; 38(10):1673-9. PubMed ID: 26424030 [TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342 [TBL] [Abstract][Full Text] [Related]
6. Aging, estrogen loss and epoxyeicosatrienoic acids (EETs). Lee AR; Pechenino AS; Dong H; Hammock BD; Knowlton AA PLoS One; 2013; 8(8):e70719. PubMed ID: 23967089 [TBL] [Abstract][Full Text] [Related]
7. Plasma epoxyeicosatrienoic acids and diabetes-related cardiovascular disease: The cardiovascular health study. Lemaitre RN; Jensen PN; Zeigler M; Fretts AM; Umans JG; Howard BV; Sitlani CM; McKnight B; Gharib SA; King IB; Siscovick DS; Psaty BM; Sotoodehnia N; Totah RA EBioMedicine; 2022 Sep; 83():104189. PubMed ID: 35930887 [TBL] [Abstract][Full Text] [Related]
8. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA. Diani-Moore S; Ma Y; Gross SS; Rifkind AB Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719 [TBL] [Abstract][Full Text] [Related]
9. A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation. Duflot T; Pereira T; Roche C; Iacob M; Cardinael P; Hamza NE; Thuillez C; Compagnon P; Joannidès R; Lamoureux F; Bellien J Anal Bioanal Chem; 2017 Mar; 409(7):1845-1855. PubMed ID: 27981341 [TBL] [Abstract][Full Text] [Related]
10. The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins. Yang T; Peng R; Guo Y; Shen L; Zhao S; Xu D Lipids Health Dis; 2013 Oct; 12():151. PubMed ID: 24148690 [TBL] [Abstract][Full Text] [Related]
11. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids. Karkhanis A; Tram NDT; Chan ECY Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841 [TBL] [Abstract][Full Text] [Related]
12. Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies. Jiang H; McGiff JC; Fava C; Amen G; Nesta E; Zanconato G; Quilley J; Minuz P Am J Hypertens; 2013 Feb; 26(2):271-8. PubMed ID: 23382413 [TBL] [Abstract][Full Text] [Related]
13. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry. Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834 [TBL] [Abstract][Full Text] [Related]
14. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs. Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825 [TBL] [Abstract][Full Text] [Related]